Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Urinary Microbiome and Bladder Cancer: Susceptibility and Immune Responsiveness

The Urinary Microbiome and Bladder Cancer: Susceptibility and Immune Responsiveness Bladder cancer is a highly prevalent disease worldwide and is associated with a high mortality rate. Across all stages of bladder cancer, immunotherapy has now become the cornerstone of treatment. The commensal microbiome has become a major focus of research given its impact on numerous states of human health and disease. Many links between commensal microbes and immune function have been reported. Recently a commensal urinary microbiome has been identified and characterized in healthy individuals by several research groups. The urinary microbiome is now emerging as an important factor influencing bladder cancer development and therapeutic responsiveness. In this report, we identify findings from important clinical and mechanistic studies on the urinary microbiome and future opportunities to impact prevention and treatment of bladder cancer. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Bladder Cancer IOS Press

The Urinary Microbiome and Bladder Cancer: Susceptibility and Immune Responsiveness

Download PDF
11 pages

Loading next page...
 
/lp/ios-press/the-urinary-microbiome-and-bladder-cancer-susceptibility-and-immune-a4n7Ziq8jg

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
IOS Press
Copyright
Copyright © 2020 © 2020 – IOS Press and the authors. All rights reserved
ISSN
2352-3727
eISSN
2352-3735
DOI
10.3233/BLC-200277
Publisher site
See Article on Publisher Site

Abstract

Bladder cancer is a highly prevalent disease worldwide and is associated with a high mortality rate. Across all stages of bladder cancer, immunotherapy has now become the cornerstone of treatment. The commensal microbiome has become a major focus of research given its impact on numerous states of human health and disease. Many links between commensal microbes and immune function have been reported. Recently a commensal urinary microbiome has been identified and characterized in healthy individuals by several research groups. The urinary microbiome is now emerging as an important factor influencing bladder cancer development and therapeutic responsiveness. In this report, we identify findings from important clinical and mechanistic studies on the urinary microbiome and future opportunities to impact prevention and treatment of bladder cancer.

Journal

Bladder Cancer – IOS Press

Published: Sep 21, 2020

References

  • Estimates of worldwide burden of cancer in GLOBOCAN 2008
    Ferlay
  • Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
    Knowles
  • Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer
    Honeycutt
  • Cancer statistics, 2009
    Jemal
  • Bladder cancer
    Sanli
  • EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
    Babjuk
  • Non-muscle invasive bladder cancer risk stratification
    Isharwal
  • EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin
    Cambier
  • The secret lives of the pathogenic mycobacteria
    Cosma
  • Age, menopausal status and the bladder microbiome
    Curtiss
  • The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults
    Lewis
  • Evidence of uncultivated bacteria in the adult female bladder
    Wolfe
  • Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder
    Hilt
  • Utility of 16S rRNA PCR performed on clinical specimens in patient management
    Akram
  • Urinary pellet sample preparation for shotgun proteomic analysis of microbial infection and host-pathogen interactions
    Yu
  • Diagnosing inflammation and infection in the urinary system via proteomics
    Yu
  • Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury
    Fouts
  • Estrogenic action on innate defense mechanisms in the urinary tract
    Lüthje
  • Urinary tract infection pathogenesis: host factors
    Stapleton AE
  • Genetics of innate immunity and UTI susceptibility
    Ragnarsdottir
  • Mini-review: perspective of the microbiome in the pathogenesis of urothelial carcinoma
    Xu
  • The urinary microbiome associated with bladder cancer
    Bucevic
  • Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China
    Wu
  • Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models
    McConnell
  • Gram-positive anaerobic cocci–commensals and opportunistic pathogens
    Murphy
  • The interplay of extracellular matrix and microbiome in urothelial bladder cancer
    Alfano
  • Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer
    Aso
  • Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial
    Aso
  • Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium Bovis (bacillus Calmette-Guerin)
    Seow
  • Habitual intake of lactic acid bacteria and risk reduction of bladder cancer
    Ohashi
  • Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancer
    Naito
  • Lactobacilli secreting a tumor antigen and IL15 activates neutrophils and dendritic cells and generates cytotoxic T lymphocytes against cancer cells
    Kandasamy
  • The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
    Matson
  • Role of urothelial cells in BCG immunotherapy for superficial bladder cancer
    Bevers
  • Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer
    Biot
  • The fate of bacillus Calmette-Guerin after intravesical instillation
    Durek
  • Oncogenic activation of Pak1-dependent pathway of macropinocytosis determines BCG entry into bladder cancer cells
    Redelman-Sidi
  • The Canonical Wnt Pathway Drives Macropinocytosis in Cancer
    Redelman-Sidi
  • Novel insights into the mechanism of action of intravesical immunomodulators
    Mitropoulos DN
  • BCG-induced interleukin-6 upregulation and BCG internalization in well and poorly differentiated human bladder cancer cell lines
    Bevers
  • Molecular analyte profiling of the early events and tissue conditioning following intravesical bacillus calmette-guerin therapy in patients with superficial bladder cancer
    Bisiaux
  • Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer
    de
  • Role of Th1 and Th2 cytokines in BCG-induced IFN-gamma production: cytokine promotion and simulation of BCG effect
    Luo
  • Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer
    Bohle
  • Macrophages and control of granulomatous inflammation in tuberculosis
    Flynn
  • Histological parameters and pitfalls in the interpretation of bladder biopsies in bacillus Calmette-Guerin treatment of superficial bladder cancer
    Lage
  • HLA-DR expression by high grade superficial bladder cancer treated with BCG
    Prescott
  • Class I and class II HLA antigen expression by transitional cell carcinoma of the bladder: correlation with T-cell infiltration and BCG treatment
    Stefanini
  • Markers predicting response to bacillus Calmette-Guerin immunotherapy in high-risk bladder cancer patients: a systematic review
    Zuiverloon
  • Blocking IL-10 enhances bacillus Calmette-Guerin induced T helper Type 1 immune responses and anti-bladder cancer immunity
    Luo Y
  • Induction of TH1- and TH2-associated cytokine mRNA in mouse bladder following intravesical growth of the murine bladder tumor MB49 and BCG immunotherapy
    McAveney
  • IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer
    Riemensberger
  • Prognostic value of a T helper 1 urinary cytokine response after intravesical bacillus Calmette-Guerin treatment for superficial bladder cancer
    Saint
  • Requirement of a thymus dependent immune response for BCG-mediated antitumor activity
    Ratliff
  • Cultured milk, yogurt, and dairy intake in relation to bladder cancer risk in a prospective study of Swedish women and men
    Larsson
  • Association of the commensal urinary microbiome with response to Bacillus Calmette-Guérin (BCG) immunotherapy in nonmuscle invasive bladder cancer
    Sweis